Featured Posts
JAMA Study on Price of Diabetes Medicines is Deceiving and Threatens Medical Innovation
In a recent study by the activist-funded JAMA Network, researchers erroneously “determined” that the price of diabetes medicines, like insulins, SGLT2 inhibitors, and…
Commentary
Biden Budget Would Expand Devastating Drug Price Controls
President Biden’s new proposed budget for Fiscal Year 2025 calls for an expansion of the drug price controls passed in the Inflation Reduction Act (IRA). These…
Commentary
ATR Supports Bipartisan Bill that Expands Health Savings Accounts
In February, the House of Representatives placed H.R.5688, the Bipartisan HSA Improvement Act, on the Union Calendar making it eligible for floor consideration. This recent movement…
Commentary
Filtered Posts
Conservative Groups Urge Biden Admin to Oppose Cuts to Medicare Advantage
Letter
ATR Urges Lawmakers to Oppose Bill that Undermines the Contact Lens Rule
Commentary
Senate HELP Committee to Hold Hearing on Prescription Drug Prices
Commentary
Medicare Advantage Report Ignores Benefits of Competition in Program
Commentary
ATR Submits Comments Opposing Misuse of Bayh-Dole March-In Rights
Commentary
ATR Celebrates the 20th Anniversary of Health Savings Accounts
Commentary
Misuse of Bayh-Dole March-In Rights Would Stunt Medical Innovation, Threaten American Competitiveness
Commentary
IRA Drug Price Controls Hearing Provides Valuable Insight on Policy’s Negative Effects
Commentary
ATR Supports Bills to Expand Health Savings Accounts
Commentary
The High Cost of Democrats’ Drug Price Controls
Commentary